Topics: COVID-19
Events
-
-
AAHMS webinar – COVID-19: Where to from here?
-
Tweetchats with PRAXIS and ACTA
-
Best Practice Guidance for Clinical Trial Sites in COVID-19: Consolidating the information
-
Trial Participants & COVID-19: considerations and strategies for running trials during the pandemic
-
Clinical Trials for COVID-19 Treatment and Prevention
-
Pharmacovigilance and Regulatory Affairs & COVID-19: considerations and strategies for running trials during the pandemic
-
Private Sector & COVID-19: considerations and strategies for running trials during the pandemic
-
Academics & COVID-19: considerations and strategies for running trials during the pandemic
-
Role of Clinical Trial Sponsors & COVID-19: considerations and strategies for running trials during the pandemic
-
Ethics Committees and Governance & COVID-19: considerations and strategies for running trials during the pandemic
-
Jurisdictions: Federal/States & COVID-19: considerations and strategies for running trials during the pandemic
News
-
COVID-19 Expert Database
-
CTTI recommendations for best practice in clinical trials during COVID-19 pandemic
-
Tweetchats with PRAXIS and ACTA
-
FDA releases final update on managing clinical trials during COVID-19
-
ACTA statement on COVID-19
-
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance
-
COVID-19 and clinical trial updates
-
State and Territory Clinical Trials Contacts
-
The Lancet COVID-19 Resource Centre
-
Vaccines alone won’t keep Australia COVID-safe, review finds
-
COVID-19: Queensland Health Operational Guidance for sponsors, trial sites, ethics committees, research governance officer/s and researchers
-
National Medical Stockpile: Supply of experimental medicines to support clinical trials
-
NSW Health COVID-19 Research Grants
-
FIND AND SHARE CLINICAL TRIAL SOLUTIONS AT BEYOND COVID-19: A SOLUTION-FOCUSSED FORUM
-
Australian Clinical Trials Alliance celebrating and honouring clinical trials on International Clinical Trials Day
-
ACTA STInG: signatories to open letters addressing statistical analysis and data integrity in COVID-19 publications
-
Media Release: Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia
-
Statistical Considerations for Clinical Trials During the COVID-19 Public Health Emergency: Guidance for Industry
-
MRFF Grant Opportunity
-
Symposium: Social and ethical implications of the COVID-19 pandemic
-
Australian Commission on Safety and Quality in Health Care extends timeline for National Clinical Trials Governance Pilot due to COVID-19 pandemic
-
COVID-19: Guidance on Australian clinical trials for institutions, HRECs, researchers and sponsors
-
NHMRC advice regarding grant administration matters
-
New South Wales Office for Health and Medical Research COVID-19 Guidance